CROSS-REACTIVITY WITH NORMAL ANTIGENS IN COMMERCIAL ANTI-CEA SERA, USED FOR IMMUNOHISTOLOGY - THE NEED FOR TISSUE CONTROLS AND ABSORPTIONS

被引：80

作者：

NAP, M ^{[1
]}

TENHOOR, KA ^{[1
]}

FLEUREN, GJ ^{[1
]}

机构：

[1] STATE UNIV GRONINGEN,DEPT PATHOL ANAT,9700 AB GRONINGEN,NETHERLANDS

来源：

关键词：

D O I：

10.1093/ajcp/79.1.25

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：25 / 31

页数：7

共 56 条

[1]

BARTAL AH, 1980, CANCER, V46, P2091, DOI 10.1002/1097-0142(19801101)46:9<2091::AID-CNCR2820460930>3.0.CO

[2]

2-D

[3]

BLAIR OM, 1974, ACTA CYTOL, V18, P510

[4]

BRONSTEIN BR, 1980, CANCER, V46, P266, DOI 10.1002/1097-0142(19800715)46:2<266::AID-CNCR2820460208>3.0.CO

[5]

2-J

BURTIN, P ;

CALMETTES, C ;

FONDANECHE, MC .

[7]

BURTIN P, 1973, J IMMUNOL, V111, P1926

[8]

BURTIN P, 1978, ANN INST PASTEUR IMM, VC129, P185

[9]

BURTIN P, 1980, BLOOD CELLS, V6, P263

CASELITZ, J ;

SEIFERT, G ;

JAUP, T .